CASI PHARMACEUTICALS INC (CASI)

followers · Follow

Sector:	HEALTH CARE
Industry:	PHARMACEUTICALS
SIC:	BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:	Wei-Wu He
Employees:	180
Web site:	casipharmaceuticals.com
9620 MEDICAL CENTER DR, STE 300, ROCKVILLE, MD, 20850 240-864-2600

EntreMed Inc

Are you looking for this stock instead?

Careside, Inc

Stock Split History
Date	Ratio
2010-07-01	1:11
2022-06-02	1:10

	All 13F Filers	Prior	Change	Hedge Funds ¹	Prior	Change

CASI Pharmaceuticals, Inc. develops and commercializes therapeutics and pharmaceutical products. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's product pipeline includes CNCT19, an autologous CD19 CAR-T investigative product for the treatment of patients with B-cell acute lymphoblastic leukemia (B-ALL) and B-NHL)

Please log in first to see chart

CASI PHARMACEUTICALS INC YCharts
Yahoo! Finance	finviz
SEC Web Site	SEC DEF 14A Filings

Shareholders (13F, 13D/G)

Current Mutual Fund/ETF Holders

Active 13D/G Filings

SEC Filings

Insiders

Short Positions

Congress

Proposed Sales

Comments and Updates

To Excel | To CSV | To TSV

Investor	History	Shares Held or Principal Amt	Market Value	% of Portfolio	Previous % of Portfolio	Rank	Change in Shares	% Change in Shares	% Ownership	Qtr 1st Owned	Est. Avg Price	Source	Source Date	Date Reported
No data available